No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RMD241220C340000
- 0.00
- 0.000.00%
15min DelayClose Dec 19 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest340.00Strike Price0.00Turnover0.00%IV46.82%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma308.77Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
With 74% Institutional Ownership, ResMed Inc. (NYSE:RMD) Is a Favorite Amongst the Big Guns
We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Stifel Maintains ResMed(RMD.US) With Hold Rating, Maintains Target Price $250
ResMed Analyst Ratings